Biomega Diagnostic Medicine
Biomega Diagnostic Medicine is a Brazil-based, privately held diagnostic laboratory outsourcing company that delivers clinical analyses and in-house pathological anatomy to public and private hospital networks across 9 states, operating a centralized 2,200 sqm processing hub and 1,000+ collection points serving 54 million exams annually.
- Company typePrivate
- Founded2017
- HeadquartersSão Paulo, Brazil
- Headcount501–1,000
- GTM typeB2B
- OfferingServices
What Biomega Diagnostic Medicine does
Biomega Diagnostic Medicine (BIOMEGA MEDICINA DIAGNÓSTICA LTDA.) is a Brazil-based diagnostic medicine outsourcing company founded in 2017 and headquartered in Barueri, São Paulo. The company provides clinical analyses (Análises Clínicas) and pathological anatomy (Anatomia Patológica) — the latter delivered 100% in-house — to public and private hospital networks across 9 Brazilian states and 50+ municipalities. Its operational model combines a 2,200 sqm centralized processing hub (NPC — Núcleo de Processamento Central) housing the largest laboratory automation track in the Americas with distributed peripheral processing units (NPPs) embedded within partner hospitals, plus ambulatory collection points and home collection services.
Biomega processes 54 million diagnostic exams annually through a network of 1,000+ collection points and employs 1,800+ professionals. Its proprietary technology stack includes the Data Analytics Biomega platform (machine learning, statistics, and mathematical algorithms applied to diagnostic data for process optimization), integrated systems for exam ordering and result release connecting hospitals, NPC, and patients, and a custom mobile application for physicians and patients. The company holds ONA III accreditation — the highest level of Brazil's National Accreditation Organization — and Controllab quality certification.
The business model is primarily B2B managed services: long-term contracts with public (SUS) and private hospital networks under which Biomega deploys and operates full in-hospital laboratory operations, covering staffing, equipment, supply chain, logistics, and quality control. A secondary B2C/professional-services revenue stream derives from ambulatory collection units (Valinhos, Campinas, Vinhedo, Monte Mor, São Vicente, Registro) and home collection for individual patients and corporate clients. GTM is enterprise field sales targeting hospital administrators and public health procurement, supplemented by WhatsApp-driven scheduling and a corporate website. No public pricing is listed; services are billed via hospital contracts, SUS reimbursement, or private insurance on a quote-based model.
Biomega Diagnostic Medicine firmographics
Firmographics- Name
- Biomega Diagnostic Medicine
- Legal name
- BIOMEGA MEDICINA DIAGNÓSTICA LTDA.
- Website
- https://biomega.com.br
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Biomega Diagnostic Medicine is a Brazil-based, privately held diagnostic laboratory outsourcing company that delivers clinical analyses and in-house pathological anatomy to public and private hospital networks across 9 states, operating a centralized 2,200 sqm processing hub and 1,000+ collection points serving 54 million exams annually.
- Ownership category
- akta.pro rank
Biomega Diagnostic Medicine industry classification
Industry- Product category
- Diagnostic Laboratory Services
- NAICS
- Medical Laboratories (621511)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Central Laboratory Services (Core Lab Operations) (HLAGAEAA)
- akta.pro secondary industries
- Anatomic Pathology (Histopathology & Cytopathology) (HLAFAMAA), Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels) (HLAAALAC), Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB)
Keywords
Where Biomega Diagnostic Medicine is headquartered
LocationHeadquarters
- HQ city
- São Paulo
- HQ country
- Brazil
- HQ region
- Latin America
Offices8 records
Markets served
Biomega Diagnostic Medicine business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Supply Chain, Technology or R&D, Marketing or Sales
Revenue model
- Hospital Laboratory Outsourcing Services: B2B contract model where Biomega operates and manages full in-house diagnostic laboratory operations (analyses cliniques and anatomical pathology) within partner hospitals, including staffing, equipment, supplies, logistics, and quality management. Revenue is derived from service contracts with public hospital networks and private hospital groups.
- Ambulatorial and Home Collection Services: Outpatient collection points and home collection services for individual patients and corporate clients (e.g., admission/periodic employee exams). Revenue generated per test or as part of corporate health packages.
Go-to-market motion2 records
Distribution channels4 records
Marketing channels2 records
Biomega Diagnostic Medicine product offering
Product offeringCore offering
Biomega Diagnostic Medicine provides outsourced clinical analyses (hematology, immunochemistry, microbiology, molecular biology, flow cytometry, etc.) and in-house pathological anatomy services to public and private hospitals across Brazil. The company operates a 2,200 sqm central processing hub (NPC), embeds peripheral processing labs (NPP) inside partner hospitals, and runs ambulatory collection units and home collection services for individual patients.
Product overview
Biomega Diagnostic Medicine operates as a diagnostic medicine provider offering outsourced clinical laboratory and pathological anatomy services to hospitals. The portfolio consists of core laboratory services (Análises Clínicas and Anatomia Patológica 100% internal), operational modules (NPP peripheral processing units installed in hospitals, outpatient collection points, and home collection services), infrastructure (Central Processing Hub/NPC), analytics capabilities (Data Analytics tool), and patient-facing digital interfaces (results portal and mobile APP). The company serves public and private hospital networks across 9 Brazilian states with 24/7 operations.
Differentiator
Problem solved
Functional benefit
Products and services
- Análises Clínicas (Clinical Analyses)
Quantifiable outcome
- 54 million diagnostic exams processed annually across the network
- +2 more outcomes
Companies that use Biomega Diagnostic Medicine
Customer profileSegments3 records
Ideal customer profiles3 records
Biomega Diagnostic Medicine technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Biomega Diagnostic Medicine partnerships and signals
Strategic signalScale indicators7 records
Recent moves6 records
Expansion highlights6 records
Biomega Diagnostic Medicine competitors and assessment
Company assessmentDirect peers
- Alliar: Brazilian diagnostics chain combining imaging and laboratory services, serving hospitals and ambulatory patients; competes with Biomega in the outsourced diagnostic medicine segment.
- Hermes Pardini: Large Brazilian diagnostic laboratory offering clinical analyses and pathology to hospitals and patients, with strong regional density — a direct competitive peer in outsourced diagnostics.
- Fleury: Major Brazilian diagnostic medicine network offering clinical analyses, pathology, and hospital lab services; competes with Biomega for private hospital contracts and ambulatory patients.
- Sabin Diagnósticos e Saúde: Brazilian diagnostics group with hospital lab outsourcing and ambulatory collection units across multiple states — directly comparable scale and business model to Biomega.
- Dasa: Largest diagnostic medicine company in Brazil, operating hospital lab outsourcing, ambulatory collection, and anatomic pathology services — directly comparable to Biomega across the full stack.
Broad incumbents
- Grupo Fleury: Diversified diagnostic medicine incumbent in Brazil offering hospital lab services, ambulatory, and specialty testing; competes with Biomega across both B2B outsourcing and ambulatory channels.
- Diagnósticos da América (Dasa): Incumbent leader in Brazilian diagnostics with a broad portfolio spanning hospitals, ambulatory, and B2B lab outsourcing — overlaps Biomega's hospital outsourcing GTM at much larger scale.
Emerging players
- Hilab: Brazilian emerging diagnostic player focused on remote/point-of-care and home-collection testing — adjacent to Biomega's home collection service with overlapping target customers.
- Labpack Diagnóstica: Brazilian emerging laboratory offering outsourced diagnostic testing to hospitals and ambulatory patients; partially comparable to Biomega's NPP outsourcing model at smaller scale.
Regional players
- Centro de Diagnósticos Brasil (CDB): São Paulo–based regional diagnostics provider offering clinical analyses and imaging — overlaps Biomega's ambulatory and hospital lab footprint in the São Paulo market.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Biomega Diagnostic Medicine social profiles
Digital presenceBiomega Diagnostic Medicine compliance and trust
Trust signalCompliance2 records
Biomega Diagnostic Medicine financial estimates
Financial estimateRevenue estimate
Valuation estimate
Biomega Diagnostic Medicine leadership team
Management profileNumber of profiles
Biomega Diagnostic Medicine funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Biomega Diagnostic Medicine M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Biomega Diagnostic Medicine
What does Biomega Diagnostic Medicine do?
Biomega Diagnostic Medicine provides outsourced clinical analyses (hematology, immunochemistry, microbiology, molecular biology, flow cytometry, etc.) and in-house pathological anatomy services to public and private hospitals across Brazil. The company operates a 2,200 sqm central processing hub (NPC), embeds peripheral processing labs (NPP) inside partner hospitals, and runs ambulatory collection units and home collection services for individual patients.
Is Biomega Diagnostic Medicine a public or private company?
Biomega Diagnostic Medicine is a private company. It is classified as unknown and is currently operating.
When was Biomega Diagnostic Medicine founded?
Biomega Diagnostic Medicine was founded in 2017. It employs 501 to 1,000 people.
Where is Biomega Diagnostic Medicine based?
Biomega Diagnostic Medicine is headquartered in São Paulo, Brazil, in the Latin America region.
How does Biomega Diagnostic Medicine make money?
Two revenue lines are on record. Hospital Laboratory Outsourcing Services are the primary driver. The others are ambulatorial and Home Collection Services.
Who are Biomega Diagnostic Medicine's main competitors?
Direct peers on record are Alliar, Hermes Pardini, Fleury, Sabin Diagnósticos e Saúde and Dasa. Broad incumbents are Grupo Fleury and Diagnósticos da América (Dasa). Emerging players are Hilab and Labpack Diagnóstica. Centro de Diagnósticos Brasil (CDB) is listed as a regional player.
Does Biomega Diagnostic Medicine have an API?
No public API is recorded for Biomega Diagnostic Medicine.
What industry is Biomega Diagnostic Medicine in?
Biomega Diagnostic Medicine's product category is Diagnostic Laboratory Services. Its primary akta.pro industry code is HLAGAEAA, Central Laboratory Services (Core Lab Operations), with a secondary code of HLAFAMAA, Anatomic Pathology (Histopathology & Cytopathology). Its NAICS code is 621511 and its SIC code is 8071.